Martek Biosciences Corp.
Shares of the nutritional supplement maker fell $2.02, or 7 percent, to $25.79 yesterday on news that third-quarter revenue for the Columbia company was slightly below analyst estimates.
Martek Biosciences Corp.
Shares of the nutritional supplement maker fell $2.02, or 7 percent, to $25.79 yesterday on news that third-quarter revenue for the Columbia company was slightly below analyst estimates.